Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Recruiting · NCT04541082 · Registry updated 2025-12-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | Choroid Plexus Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Teratoid Rhabdoid Tumor, Typical Teratoid Rhabdoid Tumor, anaplastic astrocytoma, anaplastic ependymoma, anaplastic meningioma, anaplastic oligodendroglioma, anaplastic pleomorphic xanthoastrocytoma, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, cerebral ventricle cancer, diffuse astrocytoma, diffuse midline glioma, H3 K27M-mutant, ependymoma, epithelial neoplasm, glioblastoma, glioma, gliomatosis cerebri, gliosarcoma, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligodendroglioma, pilocytic astrocytoma, pineal body neoplasm, primitive neuroectodermal tumor, tumor of meninges, vascular cancer | Recruiting | Phase 1 | 2025-12-18 | NCT04541082 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jazz Pharmaceuticals | 60 |
| National Institutes of Health (NIH) | 667 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health | Bethesda | United States | 10 |